Photo by peterconlan from unsplash
Despite receiving standard half‐life (SHL) factor VIII (FVIII) concentrates prophylaxis, some severe haemophilia A (HA) patients still encounter spontaneous breakthrough bleeding. Individualized pharmacokinetic (PK)‐guided dosing of extended half‐life (EHL) FVIII… Click to show full abstract
Despite receiving standard half‐life (SHL) factor VIII (FVIII) concentrates prophylaxis, some severe haemophilia A (HA) patients still encounter spontaneous breakthrough bleeding. Individualized pharmacokinetic (PK)‐guided dosing of extended half‐life (EHL) FVIII concentrates may reduce their bleeding events.
Keywords:
standard half;
half life;
life;
factor viii;
low dose
Journal Title: Haemophilia
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Haemophilia
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!